Replimune Group Files 8-K on Financials
Ticker: REPL · Form: 8-K · Filed: 2025-11-06T00:00:00.000Z
Sentiment: neutral
Topics: financial-results, sec-filing
Related Tickers: REPL
TL;DR
Replimune Group filed an 8-K on Nov 6, 2025, updating on financials. Details TBD.
AI Summary
Replimune Group, Inc. filed an 8-K on November 6, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, but does not disclose specific financial figures or operational details within the provided text.
Why It Matters
This filing indicates Replimune Group, Inc. is providing an update on its financial status and operational results to the SEC, which is important for investors to monitor company performance.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for reporting financial results and does not contain any immediately apparent negative news or significant changes.
Key Players & Entities
- Replimune Group, Inc. (company) — Registrant
- November 6, 2025 (date) — Date of earliest event reported
- 001-38596 (other) — SEC File Number
- 500 Unicorn Park Drive Suite 303 Woburn, MA 01801 (address) — Principal executive offices
- (781) 222-9600 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on Replimune Group, Inc.'s results of operations and financial condition, and to include financial statements and exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on November 6, 2025.
What is Replimune Group, Inc.'s SEC file number?
Replimune Group, Inc.'s SEC file number is 001-38596.
Where are Replimune Group, Inc.'s principal executive offices located?
Replimune Group, Inc.'s principal executive offices are located at 500 Unicorn Park Drive Suite 303 Woburn, MA 01801.
What is the telephone number for Replimune Group, Inc.?
The telephone number for Replimune Group, Inc. is (781) 222-9600.
Filing Stats: 515 words · 2 min read · ~2 pages · Grade level 11.4 · Accepted 2025-11-06 08:20:39
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share REPL The Nasdaq Stock Mar
Filing Documents
- tm2530417d1_8k.htm (8-K) — 26KB
- tm2530417d1_ex99-1.htm (EX-99.1) — 59KB
- 0001104659-25-107438.txt ( ) — 255KB
- repl-20251106.xsd (EX-101.SCH) — 3KB
- repl-20251106_lab.xml (EX-101.LAB) — 33KB
- repl-20251106_pre.xml (EX-101.PRE) — 22KB
- tm2530417d1_8k_htm.xml (XML) — 4KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On November 6, 2025, Replimune Group, Inc. (the "Company") issued a news release announcing its financial results for the second fiscal quarter ended September 30, 2025 and certain corporate updates. A copy of the news release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. In accordance with General Instruction B.2 of Form 8-K, the information in Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly stated by specific reference in such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. Exhibit No. Description 99.1 News Release dated November 6, 2025 104 Cover page interactive data file (formatted as Inline XBRL)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. REPLIMUNE GROUP, INC. Date: November 6, 2025 By: /s/ Sushil Patel Sushil Patel Chief Executive Officer